Naibec Signs Transfer Agreement with UK Biopharmaceutical Company for Multi-Target Anticancer Agent Substance

[Asia Economy Reporter Eunmo Koo] Nivek is partnering with a UK-based biopharmaceutical company to jointly research and develop a multi-target anticancer drug.

On the 19th, Nivek announced that it has signed a material transfer agreement for its peptide-based drug delivery system, NIPEP-TPP, with the UK biopharmaceutical company to improve new drug candidates aimed at developing multi-target anticancer drugs. This is the second global material transfer and new drug co-development achievement following last year's contract with a US-based big pharma.

Through this agreement, Nivek will receive candidate proteins from the UK pharmaceutical company and apply the NIPEP-TPP drug delivery system to provide targeting and penetration functionalities, supplying improved new drug candidate materials. Once efficacy verification is completed, it is expected to lead to a commercial contract.

NIPEP-TPP offers advantages such as effective drug delivery, selective targeting, and penetration to the intended site, reducing side effects while maximizing therapeutic effects. The company explained, "By utilizing Nivek's NIPEP-TPP, it is possible to enhance the efficacy and reduce side effects not only of existing marketed drugs but also of new drugs under development, which has led to continuous collaboration requests from overseas pharmaceutical companies."

A Nivek representative stated, "The primary goal is to apply Nivek's technology to the anticancer drug candidates in the pipeline held by the UK pharmaceutical company to upgrade the efficacy of the candidate substances to a new level. Since commercial contracts are possible once efficacy verification is completed, we expect a high possibility of commercialization."

He added, "If the multi-target anticancer drug developed through this collaboration is commercialized, Nivek's drug delivery technology applied to each therapeutic agent can be licensed or exclusively contracted, resulting in a significant effect of securing an excellent revenue model."

This content was produced with the assistance of AI translation services.